Jefferies Financial Group Reiterates Buy Rating for ConvaTec Group (LON:CTEC)

ConvaTec Group (LON:CTEC)‘s stock had its “buy” rating reiterated by stock analysts at Jefferies Financial Group in a report released on Friday, MarketBeat.com reports. They presently have a GBX 325 price objective on the stock. Jefferies Financial Group’s price objective would indicate a potential upside of 38.89% from the company’s previous close.

Several other research analysts also recently weighed in on CTEC. Citigroup reiterated an “outperform” rating and issued a GBX 315 price target on shares of ConvaTec Group in a research report on Thursday, March 5th. Berenberg Bank raised their price objective on shares of ConvaTec Group from GBX 330 to GBX 340 and gave the company a “buy” rating in a research report on Thursday, January 22nd. Deutsche Bank Aktiengesellschaft restated a “buy” rating and set a GBX 315 price objective on shares of ConvaTec Group in a research report on Wednesday. Finally, Stifel Nicolaus restated a “buy” rating and set a GBX 315 price objective on shares of ConvaTec Group in a research report on Wednesday, March 11th. Nine research analysts have rated the stock with a Buy rating, Based on data from MarketBeat, ConvaTec Group presently has an average rating of “Buy” and an average price target of GBX 319.67.

ConvaTec Group Stock Up 4.5%

CTEC opened at GBX 234 on Friday. The company has a current ratio of 1.53, a quick ratio of 0.96 and a debt-to-equity ratio of 106.19. ConvaTec Group has a 1-year low of GBX 209.40 and a 1-year high of GBX 311.20. The company has a market capitalization of £4.57 billion, a PE ratio of 27.21, a PEG ratio of 0.93 and a beta of 0.84. The firm’s 50 day simple moving average is GBX 230.52 and its two-hundred day simple moving average is GBX 234.88.

Insider Activity at ConvaTec Group

In other news, insider Jonny Mason sold 291,149 shares of the firm’s stock in a transaction on Monday, March 16th. The shares were sold at an average price of GBX 234, for a total transaction of £681,288.66. 0.95% of the stock is owned by insiders.

ConvaTec Group Company Profile

ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, and bladder cancer.